Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Perspectives of Therapeutic Drug Monitoring of Biological Agents in Non-Infectious Uveitis Treatment: A Review.
Busto-Iglesias M, Rodríguez-Martínez L, Rodríguez-Fernández CA, González-López J, González-Barcia M, de Domingo B, Rodríguez-Rodríguez L, Fernández-Ferreiro A, Mondelo-García C. Busto-Iglesias M, et al. Pharmaceutics. 2023 Feb 25;15(3):766. doi: 10.3390/pharmaceutics15030766. Pharmaceutics. 2023. PMID: 36986627 Free PMC article. Review.
Efficacy and safety of immunomodulatory drugs in patients with non-infectious intermediate and posterior uveitis, panuveitis and macular edema: A systematic literature review.
Gómez-Gómez A, Loza E, Rosario MP, Espinosa G, de Morales JMGR, Herrera JM, Muñoz-Fernández S, Rodríguez-Rodríguez L, Cordero-Coma M; Spanish Society of Ocular Inflammation (SEIOC). Gómez-Gómez A, et al. Semin Arthritis Rheum. 2020 Dec;50(6):1299-1306. doi: 10.1016/j.semarthrit.2020.08.010. Epub 2020 Aug 28. Semin Arthritis Rheum. 2020. PMID: 33065425
Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study.
Rivas AB, Lopez-Picado A, Calamia V, Carreño E, Cocho L, Cordero-Coma M, Fonollosa A, Francisco Hernandez FM, Garcia-Aparicio A, Garcia-Gonzalez J, Mondejar JJ, Lojo-Oliveira L, Martínez-Costa L, Munoz S, Peiteado D, Pinto JA, Rodriguez-Lozano B, Pato E, Diaz-Valle D, Molina E, Tebar LA, Rodriguez-Rodriguez L; CoTHEIA Study Group. Rivas AB, et al. BMJ Open. 2022 Mar 22;12(3):e051378. doi: 10.1136/bmjopen-2021-051378. BMJ Open. 2022. PMID: 35318229 Free PMC article.
Corneal Biomechanics in Non-infectious Uveitis Measured by Corvis ST: A Pilot Study.
Borrego-Sanz L, Morales-Fernández L, Saénz-Francés San Baldomero F, Díaz Valle D, Pato Cour E, Méndez Fernández R, García Feijóo J, Rodríguez Rodríguez L. Borrego-Sanz L, et al. Ocul Immunol Inflamm. 2023 Nov;31(9):1765-1771. doi: 10.1080/09273948.2022.2108462. Epub 2022 Aug 18. Ocul Immunol Inflamm. 2023. PMID: 35980346
Therapeutic Response After Immunosuppressive Drug Prescription in Non-infectious Uveitis: A Survival Analysis.
Gómez-Gómez A, Madrid-Garcia A, Borrego-Sanz L, Álvarez-Hernández P, Arriola-Villalobos P, Pérez-Sancristobal I, Benítez Del Castillo JM, Mendez-Fernandez R, Pato-Cour E, Díaz-Valle D, Rodriguez-Rodriguez L. Gómez-Gómez A, et al. Ophthalmol Ther. 2023 Feb;12(1):139-153. doi: 10.1007/s40123-022-00587-8. Epub 2022 Oct 20. Ophthalmol Ther. 2023. PMID: 36266560 Free PMC article.
285 results